(vi)$12,800,610, and $260,175, respectively, relate to performance share units and related dividend rights granted on January 16, 2025, which have a performance period that will end on December 31, 2027 (using an estimate of a 250% payout).
(2)Of the amount reported under each of the “Change in Control Termination” column and the “Termination for Death or Disability” column:
(i)$3,583,544, and $6,798, respectively, relate to restricted stock units and related dividend rights granted on January 19, 2023, which are scheduled to vest January 19, 2026;
(ii)$8,958,951, and $405,459, respectively, relate to performance share units and related dividend rights granted on January 19, 2023, which have a performance period that ended on December 31, 2025 (using an estimate of a 250% payout);
(iii)$3,232,625, and $0, respectively, relate to restricted stock units and related dividend rights granted on January 18, 2024, which are scheduled to vest January 18, 2027;
(iv)$8,081,561, and $284,716, respectively, relate to performance share units and related dividend rights granted on January 18, 2024, which have a performance period that will end on December 31, 2026 (using an estimate of a 250% payout);
(v)$1,976,364, and $0, respectively, relate to restricted stock units and related dividend rights granted on January 16, 2025, which are scheduled to vest January 16, 2028; and
(vi)$4,940,910, and $100,425, respectively, relate to performance share units and related dividend rights granted on January 16, 2025, which have a performance period that will end on December 31, 2027 (using an estimate of a 250% payout).
(3)Of the amount reported under each of the “Change in Control Termination” column and the “Termination for Death or Disability” column:
(i)$2,506,617, and $4,755, respectively, relate to restricted stock units and related dividend rights granted on January 19, 2023, which are scheduled to vest January 19, 2026;
(ii)$6,266,542, and $283,608, respectively, relate to performance share units and related dividend rights granted on January 19, 2023, which have a performance period that ended on December 31, 2025 (using an estimate of a 250% payout);
(iii)$2,299,239, and $0, respectively, relate to restricted stock units and related dividend rights granted on January 18, 2024, which are scheduled to vest January 18, 2027;
(iv)$5,748,097, and $202,508, respectively, relate to performance share units and related dividend rights granted on January 18, 2024, which have a performance period that will end on December 31, 2026 (using an estimate of a 250% payout);
(v)$1,360,134, and $0, respectively, relate to restricted stock units and related dividend rights granted on January 16, 2025, which are scheduled to vest January 16, 2028; and
(vi)$3,400,335, and $69,113, respectively, relate to performance share units and related dividend rights granted on January 16, 2025, which have a performance period that will end on December 31, 2027 (using an estimate of a 250% payout).
(4)Of the amount reported under each of the “Change in Control Termination” column and the “Termination for Death or Disability” column:
(i)$2,506,617, and $4,755, respectively, relate to restricted stock units and related dividend rights granted on January 19, 2023, which are scheduled to vest January 19, 2026;
(ii)$6,266,542, and $283,608, respectively, relate to performance share units and related dividend rights granted on January 19, 2023, which have a performance period that ended on December 31, 2025 (using an estimate of a 250% payout);
(iii)$2,299,239, and $0, respectively, relate to restricted stock units and related dividend rights granted on January 18, 2024, which are scheduled to vest January 18, 2027;
(iv)$5,748,097, and $202,508, respectively, relate to performance share units and related dividend rights granted on January 18, 2024, which have a performance period that will end on December 31, 2026 (using an estimate of a 250% payout);
(v)$1,360,134, and $0, respectively, relate to restricted stock units and related dividend rights granted on January 16, 2025, which are scheduled to vest January 16, 2028; and
(vi)$3,400,335, and $69,113, respectively, relate to performance share units and related dividend rights granted on January 16, 2025, which have a performance period that will end on December 31, 2027 (using an estimate of a 250% payout).
(5)Of the amount reported under each of the “Change in Control Termination” column and the “Termination for Death or Disability” column:
(i)$2,506,617, and $4,755, respectively, relate to restricted stock units and related dividend rights granted on January 19, 2023, which are scheduled to vest January 19, 2026;
(ii)$6,266,542, and $283,608, respectively relate to performance share units and related dividend rights granted on January 19, 2023, which have a performance period that ended on December 31, 2025 (using an estimate of a 250% payout);